Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.13 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.35 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.120 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.172EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.320EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.91EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.55.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LQ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDKEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used